Literature DB >> 10323401

The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.

P Correa1, J Rastad, P Schwarz, G Westin, A Kindmark, E Lundgren, G Akerström, T Carling.   

Abstract

Vitamin D regulates parathyroid cell proliferation and secretion of PTH. Increased prevalence of the polymorphic vitamin D receptor (VDR) alleles b, a, and T has been reported in sporadic primary hyperparathyroidism (PHPT), suggesting that these genetic variants may predispose to the disease. Recently, another polymorphism in the VDR gene was related to bone mineral density, and this VDR-FokI polymorphism causes different lengths of the VDR, implying possible functional consequences. The VDR-FokI polymorphism was studied in 182 postmenopausal women with sporadic PHPT and in matched controls. No significant differences in distribution of the VDR-FokI genotypes could be detected between the groups, although there was a tendency toward overrepresentation of the F allele in the PHPT patients (P = 0.05). There were no significant associations with age, serum calcium, serum PTH, bone mineral density, or parathyroid tumor weight. The VDR genotypes were unrelated to VDR and PTH messenger ribonucleic acid levels in the parathyroid adenomas of 42 PHPT patients. In 23 PHPT patients, the Ca2+-PTH set-points were determined in vivo and were unrelated to the VDR alleles. We suggest that the VDR-FokI polymorphism has at most a minor pathogenic importance in the development of PHPT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323401     DOI: 10.1210/jcem.84.5.5707

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure.

Authors:  E Vigo Gago; C Cadarso-Suárez; R Perez-Fernandez; R Romero Burgos; J Devesa Mugica; C Segura Iglesias
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Bone mass pharmacogenetics and ethnic health implications.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

3.  Epigenetics meets endocrinology.

Authors:  Xiang Zhang; Shuk-Mei Ho
Journal:  J Mol Endocrinol       Date:  2011-02       Impact factor: 5.098

4.  The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.

Authors:  H Raef; S Ingemansson; S Sobhi; A Sultan; M Ahmed; M Chaudhry
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

5.  Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis.

Authors:  P Selvaraj; G Chandra; M S Jawahar; M Vidya Rani; D Nisha Rajeshwari; P R Narayanan
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

6.  Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis.

Authors:  P Selvaraj; M Vidyarani; K Alagarasu; S Prabhu Anand; P R Narayanan
Journal:  J Clin Immunol       Date:  2008-01-30       Impact factor: 8.317

7.  Renal stone disease, elevated iPTH level and normocalcemia.

Authors:  Nada B Dimkovic; Abdul Aziz Wallele; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.